Richard Pops, Chief Executive Officer of Alkermes, Inc., will present an overview of the company at 11:00am ET on Wednesday, January 30, 2002, from The Pierre Hotel in New York.
Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. We have several areas of focus, including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks, using our ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on our proprietary AIR(TM) pulmonary technology. In addition to our Cambridge, Massachusetts, headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England.
CONTACT: Alkermes, Inc.
Rebecca Peterson
Director, Investor Relations
(617) 583-6378
Copyright (C) 2002 Business Wire. All rights reserved.